| [1] |
Tan L, Jin LH, Wang YQ, et al. Clinical features, pathological characteristics, and prognosis of patients with IgA nephropathy complicated with nephrotic syndrome[J]. Sci Rep, 2025, 15(1): 1804.
doi: 10.1038/s41598-025-86081-0
|
| [2] |
Mao Y, Zhou W, Zhou Z, et al. Treatment and outcome of IgA nephropathy in children from one single center experience[J]. BMC Pediatr, 2023, 23(1): 377.
doi: 10.1186/s12887-023-04195-8
pmid: 37495962
|
| [3] |
张艳敏, 刘玉洁, 贾东华, 等. 儿童特发性膜性肾病的临床病理特点及治疗[J]. 罕少疾病杂志, 2025, 32(02): 15-7.
|
|
Zhang YM, Liu YJ, Jia DH, et al. Clinicopathological characteristics and treatment of idiopathic membranous nephropathy in children[J]. Hanshaojibing Zazhi, 2025, 32(2): 15-17.
|
| [4] |
王羽晴, 朱琳, 周萍. 黑龙江省单中心785例儿童肾活检病理分析(2002年-2019年) [J]. 肾脏病与透析肾移植杂志, 2020, 29(4): 323-7.
doi: 10.3969/j.issn.1006-298X.2020.04.005
|
|
Wang YQ, Zhu L, Zhou P. Pathological analysis of 785 pediatric renal biopsies from a single center in Heilongjiang Province (2002-2019) [J]. Shenzangbing Yu Touxi Shenyizhi Zazhi, 2020, 29(4): 323-327.
|
| [5] |
Ramachandran R, Nayak S, Kumar V, et al. Primary membranous nephropathy in children and adolescents: a single-centre report from South Asia[J]. Pediatr Nephrol, 2021, 36(5): 1217-1226.
doi: 10.1007/s00467-020-04798-8
pmid: 33108509
|
| [6] |
Huang G, Liu F, Yu L, et al. Pediatric membranous nephropathy: In the novel antigens era[J]. Front Immunol, 2022, 13: 962502.
doi: 10.3389/fimmu.2022.962502
|
| [7] |
Nishida M, Kato R, Hamaoka K. Coexisting Membranous Nephropathy and IgA Nephropathy[J]. Fetal Pediatr Pathol, 2015, 34(6): 351-354.
doi: 10.3109/15513815.2015.1087607
pmid: 26418809
|
| [8] |
Chen P, Shi SF, Qu Z, et al. Characteristics of patients with coexisting IgA nephropathy and membranous nephropathy[J]. Ren Fail, 2018, 40(1): 213-218.
doi: 10.1080/0886022X.2018.1455591
pmid: 29619862
|
| [9] |
Lee SM. Prognostic indicators of progressive renal disease in IgA nephropathy: emergence of a new histologic grading system[J]. Am J Kidney Dis, 1997, 29(6): 953-958.
pmid: 9186084
|
| [10] |
Marx BE, Marx M. Prediction in idiopathic membranous nephropathy[J]. Kidney Int, 1999, 56(2): 666-673.
pmid: 10432407
|
| [11] |
Levin A, Ahmed SB, Carrero JJ, et al. Executive summary of the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease: known knowns and known unknowns[J]. Kidney Int, 2024, 105(4): 684-701.
doi: 10.1016/j.kint.2023.10.016
pmid: 38519239
|
| [12] |
Zhou N, Wang H, Wang XY, et al. Characteristics of children with IgA nephropathy[J]. Pediatr Res, 2023, 93(3): 715-719.
doi: 10.1038/s41390-022-02080-1
|
| [13] |
Wang R, Wang M, Xia Z, et al. Long-term renal survival and related risk factors for primary membranous nephropathy in Chinese children: a retrospective analysis of 217 cases[J]. J Nephrol, 2021, 34(2): 589-596.3
doi: 10.1007/s40620-020-00816-y
|
| [14] |
王忍, 王美秋, 高春林, 等. 伴C1q沉积的儿童原发性膜性肾病的临床特点及预后[J]. 中华实用儿科临床杂志, 2021, 36(21): 1610-1613.
|
|
Wang R, Wang MQ, Gao CL, et al. Clinical features and prognosis of pediatric primary membranous nephropathy with C1q deposition[J]. Zhonghua Shiyong Erke Linchuang Zazhi, 2021, 36(21): 1610-1613.
|
| [15] |
Menon S, Valentini RP. Membranous nephropathy in children: clinical presentation and therapeutic approach[J]. Pediatr Nephrol, 2010, 25(8): 1419-1428.
doi: 10.1007/s00467-009-1324-5
pmid: 19908069
|
| [16] |
Shima Y, Nakanishi K, Sato M, et al. IgA nephropathy with presentation of nephrotic syndrome at onset in children[J]. Pediatr Nephrol, 2017, 32(3): 457-465.
doi: 10.1007/s00467-016-3502-6
pmid: 27714465
|
| [17] |
Valentini RP, Mattoo TK, Kapur G, et al. Membranous glomerulonephritis: treatment response and outcome in children[J]. Pediatr Nephrol, 2009, 24(2): 301-308.
doi: 10.1007/s00467-008-1005-9
pmid: 18846392
|
| [18] |
Aziz M, Ehsan A, Mubarak M, et al. Clinicopathologic features and the association with short-term outcome of primary membranous nephropathy in children: a single-center study from pakistan[J]. Saudi J Kidney Dis Transpl, 2020, 31(5): 1078-1084.
doi: 10.4103/1319-2442.301174
pmid: 33229772
|
| [19] |
徐可, 王芳, 王中华, 等. 儿童原发膜性肾病肾小球C1q或IgA沉积的意义探讨[J]. 中华儿科杂志, 2022, 60(9): 901-907.
|
|
Xu K, Wang F, Wang ZH, et al. Significance of glomerular C1q or IgA deposition in pediatric primary membranous nephropathy[J]. Zhonghua Erke Zazhi, 2022, 60(9): 901-907.
|
| [20] |
Sawamura M, Komatsuda A, Kaga H, et al. Membranous nephropathy with solitary polyclonal IgA deposition: A case report and literature review[J]. Clin Nephrol Case Stud, 2019, 7: 60-65.
doi: 10.5414/CNCS109807
pmid: 31673485
|
| [21] |
Knoppova B, Reily C, King RG, et al. Pathogenesis of IgA nephropathy: current understanding and implications for development of disease-specific treatment[J]. J Clin Med, 2021, 10(19): 4501.
doi: 10.3390/jcm10194501
|
| [22] |
Medjeral-Thomas NR, Cook HT, Pickering MC. Complement activation in IgA nephropathy[J]. Semin Immunopathol, 2021, 43(5): 679-690.
doi: 10.1007/s00281-021-00882-9
pmid: 34379175
|
| [23] |
Beck LH Jr, Bonegio RG, Lambeau G, et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy[J]. N Engl J Med, 2009, 361(1): 11-21.
doi: 10.1056/NEJMoa0810457
|
| [24] |
Teisseyre M, Beyze A, Perrochia H, et al. C5b-9 glomerular deposits are associated with poor renal survival in membranous nephropathy[J]. Kidney Int Rep, 2022, 8(1): 103-114.
|
| [25] |
Sethi S, Debiec H, Madden B, et al. Neural epidermal growth factor-like 1 protein (NELL-1) associated membranous nephropathy[J]. Kidney Int, 2020, 97(1): 163-174.
doi: 10.1016/j.kint.2019.09.014
|
| [26] |
Sethi S, Beck LH Jr, Glassock RJ, et al. Mayo Clinic consensus report on membranous nephropathy: proposal for a novel classification[J]. Kidney Int, 2023, 104(6): 1092-1102.
doi: 10.1016/j.kint.2023.06.032
pmid: 37795587
|
| [27] |
Doi T, Mayumi M, Kanatsu K, et al. Distribution of IgG subclasses in membranous nephropathy[J]. Clin Exp Immunol, 1984, 58(1): 57-62.
pmid: 6383668
|
| [28] |
He JW, Cui DF, Zhou XJ, et al. Concurrent IgA nephropathy and membranous nephropathy, is it an overlap syndrome?[J]. Front Immunol, 2022, 13: 846323.
doi: 10.3389/fimmu.2022.846323
|
| [29] |
D'Amico G, Colasanti G, Barbiano di Belgioioso G, et al. Long-term follow-up of IgA mesangial nephropathy: clinico-histological study in 374 patients[J]. Semin Nephrol, 1987, 7(4): 355-358.
pmid: 3445015
|
| [30] |
Hastings MC, Bursac Z, Julian BA, et al. Life expectancy for patients from the southeastern united states with IgA nephropathy[J]. Kidney Int Rep, 2017, 3(1): 99-104.
|